NXTC NextCure Inc

Price (delayed)

$4.82

Market cap

$22.06M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$8.7

Enterprise value

$10.41M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 8
Highlights
The EPS has soared by 66% YoY and by 49% from the previous quarter
NXTC's net income is up by 30% year-on-year and by 22% since the previous quarter
NextCure's equity has shrunk by 59% YoY and by 55% QoQ
The quick ratio has contracted by 28% from the previous quarter and by 4.6% YoY

Key stats

What are the main financial stats of NXTC

NXTC stock price

How has the NextCure stock price performed over time
Intraday
-6.95%
1 week
-20.07%
1 month
-23.37%
1 year
-12.84%
YTD
-66.03%
QTD
201.25%

Financial performance

How have NextCure's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$43.9M
Net income
-$42.75M
Gross margin
N/A
Net margin
N/A
NextCure's operating income has increased by 31% YoY and by 22% from the previous quarter
NXTC's net income is up by 30% year-on-year and by 22% since the previous quarter

Price vs fundamentals

How does NXTC's price correlate with its fundamentals

Growth

What is NextCure's growth rate over time

Valuation

What is NextCure stock price valuation
P/E
N/A
P/B
1.43
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 66% YoY and by 49% from the previous quarter
The P/B is 71% higher than the last 4 quarters average of 0.9
NextCure's equity has shrunk by 59% YoY and by 55% QoQ

Efficiency

How efficient is NextCure business performance
NextCure's return on invested capital has shrunk by 96% YoY and by 15% QoQ
NXTC's return on equity has dropped by 63% year-on-year but it is up by 8% since the previous quarter
NXTC's ROA is down by 33% YoY but it is up by 9% QoQ

Dividends

What is NXTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NXTC.

Financial health

How did NextCure financials performed over time
NXTC's total assets is 116% greater than its total liabilities
NXTC's total assets has dropped by 53% year-on-year and by 40% since the previous quarter
NextCure's total liabilities has decreased by 35% YoY and by 7% QoQ
NXTC's debt is 70% smaller than its equity
The debt to equity has surged by 100% since the previous quarter and by 88% year-on-year
NextCure's equity has shrunk by 59% YoY and by 55% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.